Iterum Therapeutics plc

ITRMDelisted Jun 23, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001659323

SEC filings (opens in a new tab)

Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Iterum Therapeutics plc changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of ITRM: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	17	15	−2
Shares	442.5K	226.9K	−215.6K (−48.7%)
Value	$393.4K	$184.0K	−$209.5K (−53.2%)

New holders (1)

Institutions that held Iterum Therapeutics plc at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to ITRM in Q3 2023
Institution	Shares	Value	% of portfolio
Citadel Advisors LLC	19,566	$16.2K	0.00%

Sold out (3)

Institutions that held Iterum Therapeutics plc at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of ITRM in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Apollon Wealth Management, LLC	200,000	$214.0K
UBS Group AG	48	$51
Sabby Management, LLC	75,000	–